GSK plc vs Pfizer, Inc. — Stock Comparison

GSK
GSK plc
$51.61
▼ 1.34%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 6.3/10

Q·Score Breakdown

6.3
Neutral
Overall
6.5
Neutral
8.5
Quality
7.4
5.8
Health
7
5.8
Growth
5.6
6.7
Valuation
6.7
3.1
Sentiment
5.2
GSK

High-quality business with 41% return on equity and 18% profit margins.

cautious analyst consensus — few Buy ratings.

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $57.65 (+11.7%)
8 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

GSK
PFE
13.4×
Trailing P/E
19.4×
9.9×
Forward P/E
9.4×
17.8%
Profit Margin
12.4%
72.9%
Gross Margin
75.8%
40.9%
ROE
8.9%
1.5%
Revenue Growth
-1.2%
8.4%
Earnings Growth
0.35
Beta
0.39
Price / Book
$103.0B
Market Cap
$149.8B
$35 – $62
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →